Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lyn S Pilowsky

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Schizophrenia Research|June 27, 2002
Typical antipsychotic drugs -- D(2) receptor occupancy and depressive symptoms in schizophreniaRodrigo A Bressan, Durval C Costa, Hugh M Jones, et al.
The Journal of Clinical Psychiatry|October 20, 2004
The effect of clozapine on factors controlling glucose homeostasisOliver D Howes, Fiona P Gaughran, Stephanie A Amiel, et al.
The Journal of Clinical Psychiatry|March 29, 2007
Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorderOliver D Howes, Michael J Wheeler, Lyn S Pilowsky, et al.
Synapse (New York, N.Y.)|May 23, 2006
[123I]TPCNE--a novel SPET tracer for the sigma-1 receptor: first human studies and in vivo haloperidol challengeJames M Stone, Erik Arstad, Kjell Erlandsson, et al.
Neuroimage|July 26, 2003
Analysis of D2 dopamine receptor occupancy with quantitative SPET using the high-affinity ligand [123I]epidepride: resolving conflicting findingsKjell Erlandsson, Rodrigo A Bressan, Rachel S Mulligan, et al.
Bioorganic & Medicinal Chemistry|June 17, 2006
Towards NR2B receptor selective imaging agents for PET-synthesis and evaluation of N-[11C]-(2-methoxy)benzyl (E)-styrene-, 2-naphthyl- and 4-trifluoromethoxyphenylamidineErik Arstad, Stefan Platzer, Achim Berthele, et al.
Journal of Clinical Psychopharmacology|January 25, 2003
Optimizing limbic selective D2/D3 receptor occupancy by risperidone: a [123I]-epidepride SPET studyRodrigo A Bressan, Kjell Erlandsson, Hugh M Jones, et al.
Journal of Clinical Psychopharmacology|November 18, 2006
The relationship between prolactin levels and glucose homeostasis in antipsychotic-treated schizophrenic patientsOliver D Howes, Shubulade Smith, Fiona P Gaughran, et al.
The American Journal of Psychiatry|February 3, 2004
A prospective study of impairment in glucose control caused by clozapine without changes in insulin resistanceOliver D Howes, Ajay Bhatnagar, Fiona P Gaughran, et al.
The American Journal of Psychiatry|August 6, 2003
Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patientsRodrigo A Bressan, Kjell Erlandsson, Hugh M Jones, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Schizophrenia Research|June 27, 2002
Typical antipsychotic drugs -- D(2) receptor occupancy and depressive symptoms in schizophreniaRodrigo A Bressan, Durval C Costa, Hugh M Jones, et al.
The Journal of Clinical Psychiatry|October 20, 2004
The effect of clozapine on factors controlling glucose homeostasisOliver D Howes, Fiona P Gaughran, Stephanie A Amiel, et al.
The Journal of Clinical Psychiatry|March 29, 2007
Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorderOliver D Howes, Michael J Wheeler, Lyn S Pilowsky, et al.
Synapse (New York, N.Y.)|May 23, 2006
[123I]TPCNE--a novel SPET tracer for the sigma-1 receptor: first human studies and in vivo haloperidol challengeJames M Stone, Erik Arstad, Kjell Erlandsson, et al.
Neuroimage|July 26, 2003
Analysis of D2 dopamine receptor occupancy with quantitative SPET using the high-affinity ligand [123I]epidepride: resolving conflicting findingsKjell Erlandsson, Rodrigo A Bressan, Rachel S Mulligan, et al.
Bioorganic & Medicinal Chemistry|June 17, 2006
Towards NR2B receptor selective imaging agents for PET-synthesis and evaluation of N-[11C]-(2-methoxy)benzyl (E)-styrene-, 2-naphthyl- and 4-trifluoromethoxyphenylamidineErik Arstad, Stefan Platzer, Achim Berthele, et al.
Journal of Clinical Psychopharmacology|January 25, 2003
Optimizing limbic selective D2/D3 receptor occupancy by risperidone: a [123I]-epidepride SPET studyRodrigo A Bressan, Kjell Erlandsson, Hugh M Jones, et al.
Journal of Clinical Psychopharmacology|November 18, 2006
The relationship between prolactin levels and glucose homeostasis in antipsychotic-treated schizophrenic patientsOliver D Howes, Shubulade Smith, Fiona P Gaughran, et al.
The American Journal of Psychiatry|February 3, 2004
A prospective study of impairment in glucose control caused by clozapine without changes in insulin resistanceOliver D Howes, Ajay Bhatnagar, Fiona P Gaughran, et al.
The American Journal of Psychiatry|August 6, 2003
Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patientsRodrigo A Bressan, Kjell Erlandsson, Hugh M Jones, et al.
Pageof 6